Jim Chanos China's consumer data

Chanos Loves SCTY Short; Not Happy With VRX

 

Kynikos Associates President Jim Chanos discusses his short position in SolarCity, which oil companies he’s most confidently betting against, and what he finds most shocking about the embattled drugmaker Valeant Pharmaceuticals.

Kynikos Associates President Jim Chanos details the strategy behind his short position in SolarCity, and why he is betting against leveraged oil companies.

Thursday, 17 December 2015 4:12 PM ET
Kynikos Associates President Jim Chanos weighs in on Valeant and why it is wise to remain short the embattled drugmaker.


Jim Chanos China's consumer data

LEAVE A COMMENT


Saved Articles
X
TextTExtLInkTextTExtLInk

Are you a smart investor? Join tens of thousands of sophisticated investor reading our authoritative free newsletter

* indicates required


Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up for ValueWalkPremium today and get our exclusive content for 35% off.

Use coupon code vip19 or click on the button below

Limited time offer only ENDS 11/30/2019 or after next 25 12 subscribers take advantage whichever comes first – please do not share this discount with others

 

0